Circadian changes in pharmacokinetics of Everolimus and to identify the time point relation with area under curve of Everolimus in heart transplant patients

Trial Profile

Circadian changes in pharmacokinetics of Everolimus and to identify the time point relation with area under curve of Everolimus in heart transplant patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Heart transplant rejection
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Dec 2016 New trial record
    • 26 Oct 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top